BPG is committed to discovery and dissemination of knowledge
Articles in Press
7/29/2025 10:40:05 AM | Browse: 27 | Download: 0
Category |
Oncology |
Manuscript Type |
Observational Study |
Article Title |
Concordance of programmed death-ligand 1 expression assessments determined via two immunohistochemical tests and the polymerase chain reaction method
|
Manuscript Source |
Invited Manuscript |
All Author List |
Marina A Senchukova, Natalia V Saidler, Evgeniya Yu Zubareva, Alexander B Prokofiev and Dmitry G Tagabilev |
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
Russian Science Foundation |
No. 23-25-00183 |
|
Corresponding Author |
Marina A Senchukova, MD, PhD, Professor, Scientific and Clinical Center No. 3, Petrovsky National Research Centre of Surgery, Oktyabrsky Prospekt 3, Moscow 108840, Troitsk, Russia. masenchukova@yandex.com |
Key Words |
Breast cancer; Cohen kappa index; Negative percentage agreement; Positive percentage agreement; Programmed death-ligand 1; Programmed cell death protein 1 ligand 1 |
Core Tip |
We determined the expression of programmed cell death ligand 1 in immune cells using immunohistochemistry with antibodies against programmed cell death protein 1 ligand 1 (PDCD1 LG1) and SP142 and polymerase chain reaction (PCR) and then examined the agreement between the results of three assays in patients with breast cancer (BC). All three tests were positively correlated with estrogen receptor-negative status, human epidermal growth factor receptor-2-positive (HER2+) status, and luminal B HER+, nonluminal HER+, and triple-negative BCs. Cohen's kappa index was 0.385 for PDCD1 LG1 and SP142 and 0.389 for SP142 and programmed death-ligand 1 (PCR), which is considered moderate agreement between the markers. |
Citation |
<p>Senchukova MA, Saidler NV, Zubareva EY, Prokofiev AB, Tagabilev DG. Concordance of programmed death-ligand 1 expression assessments determined via two immunohistochemical tests and the polymerase chain reaction method. <i>World J Exp Med</i> 2025; 15(3): 108984</p> |
 |
Received |
|
2025-04-27 15:35 |
 |
Peer-Review Started |
|
2025-05-04 01:31 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2025-05-14 03:21 |
 |
Revised |
|
2025-05-21 09:33 |
 |
Second Decision |
|
2025-07-28 02:38 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2025-07-29 10:40 |
 |
Articles in Press |
|
2025-07-29 10:40 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2025-08-01 05:36 |
ISSN |
2220-315x (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345